1|Page
Comprehensive Asthma: Chronic Airway
Inflammation Study Guide High-Yield Questions |
Verified Answers | Detailed Rationales NCLEX-Style
Review | Complete Study Guide for Nursing Students
Structure & Organization
This comprehensive study guide covers all aspects of asthma
pathophysiology, assessment, management, and patient education. It is
organized to support progressive learning from basic concepts to
advanced clinical application.
Section Content Area Q&A Coun
I Pathophysiology of Asthma 15
II Classification & Severity 10
III Clinical Manifestations & Assessment 15
IV Diagnostic Studies & Pulmonary Function Tests 12
V Pharmacological Management 20
VI Non-Pharmacological Management 10
,2|Page
Section Content Area Q&A Coun
VII Asthma Action Plans & Self-Management 10
VIII Special Populations (Pediatric, Geriatric, Pregnancy) 10
IX Acute Exacerbation & Status Asthmaticus 15
X Complications & Comorbidities 8
XI Patient Education & Discharge Planning 15
XII NGN Case Studies 20
Total 160
PART I: Pathophysiology of Asthma
1. A nursing student is studying the pathophysiology of asthma.
Which of the following best describes the underlying mechanism of
asthma?
A) Destruction of alveolar walls leading to air trapping
B) Chronic inflammation of the airways with reversible airflow
obstruction
C) Fixed narrowing of the airways due to scarring
D) Infectious destruction of bronchial tissue
,3|Page
Answer: B) Chronic inflammation of the airways with reversible
airflow obstruction
Rationale: Asthma is characterized by chronic airway inflammation that
leads to reversible airflow obstruction, airway hyperresponsiveness, and
variable airflow limitation. The inflammation involves mast cells,
eosinophils, T lymphocytes, and other inflammatory cells. Option A
describes emphysema. Option C describes fixed airway obstruction seen
in COPD. Option D describes infectious processes like bronchitis.
2. A nurse is explaining the early-phase (immediate) asthmatic
response to a patient. Which of the following cellular mediators is
primarily responsible for bronchoconstriction in this phase?
A) Interleukin-5
B) Histamine
C) Tumor necrosis factor-alpha
D) Leukotrienes
Answer: B) Histamine
Rationale: The early-phase response (occurring within minutes of
allergen exposure) is primarily mediated by histamine released from
mast cells. Histamine causes bronchoconstriction, mucus secretion, and
vasodilation. Interleukin-5 (A) promotes eosinophil activation. TNF-
alpha (C) is involved in chronic inflammation. Leukotrienes (D)
contribute to both early and late-phase responses.
3. Which of the following statements accurately describes the late-
phase asthmatic response?
, 4|Page
A) Occurs within minutes of allergen exposure and resolves quickly
B) Occurs 4-8 hours after exposure and involves inflammatory cell
infiltration
C) Is not responsive to bronchodilator therapy
D) Only occurs in patients with severe asthma
Answer: B) Occurs 4-8 hours after exposure and involves
inflammatory cell infiltration
Rationale: The late-phase response occurs 4-8 hours after allergen
exposure and involves recruitment of inflammatory cells (eosinophils,
neutrophils, T lymphocytes) to the airways. This response contributes to
airway hyperresponsiveness and chronic inflammation. Option A
describes the early-phase response. The late-phase response is partially
responsive to bronchodilators (C) and can occur in mild to severe asthma
(D).
4. A nurse is teaching a patient about airway remodeling in asthma.
Which of the following is a consequence of chronic, uncontrolled
airway inflammation?
A) Reversible bronchoconstriction
B) Permanent structural changes including subepithelial fibrosis and
smooth muscle hypertrophy
C) Decreased mucus production
D) Resolution of airway hyperresponsiveness
Answer: B) Permanent structural changes including subepithelial
fibrosis and smooth muscle hypertrophy
Rationale: Airway remodeling is a consequence of chronic, untreated
inflammation. It involves subepithelial fibrosis (collagen deposition),
smooth muscle hypertrophy and hyperplasia, goblet cell hyperplasia, and
Comprehensive Asthma: Chronic Airway
Inflammation Study Guide High-Yield Questions |
Verified Answers | Detailed Rationales NCLEX-Style
Review | Complete Study Guide for Nursing Students
Structure & Organization
This comprehensive study guide covers all aspects of asthma
pathophysiology, assessment, management, and patient education. It is
organized to support progressive learning from basic concepts to
advanced clinical application.
Section Content Area Q&A Coun
I Pathophysiology of Asthma 15
II Classification & Severity 10
III Clinical Manifestations & Assessment 15
IV Diagnostic Studies & Pulmonary Function Tests 12
V Pharmacological Management 20
VI Non-Pharmacological Management 10
,2|Page
Section Content Area Q&A Coun
VII Asthma Action Plans & Self-Management 10
VIII Special Populations (Pediatric, Geriatric, Pregnancy) 10
IX Acute Exacerbation & Status Asthmaticus 15
X Complications & Comorbidities 8
XI Patient Education & Discharge Planning 15
XII NGN Case Studies 20
Total 160
PART I: Pathophysiology of Asthma
1. A nursing student is studying the pathophysiology of asthma.
Which of the following best describes the underlying mechanism of
asthma?
A) Destruction of alveolar walls leading to air trapping
B) Chronic inflammation of the airways with reversible airflow
obstruction
C) Fixed narrowing of the airways due to scarring
D) Infectious destruction of bronchial tissue
,3|Page
Answer: B) Chronic inflammation of the airways with reversible
airflow obstruction
Rationale: Asthma is characterized by chronic airway inflammation that
leads to reversible airflow obstruction, airway hyperresponsiveness, and
variable airflow limitation. The inflammation involves mast cells,
eosinophils, T lymphocytes, and other inflammatory cells. Option A
describes emphysema. Option C describes fixed airway obstruction seen
in COPD. Option D describes infectious processes like bronchitis.
2. A nurse is explaining the early-phase (immediate) asthmatic
response to a patient. Which of the following cellular mediators is
primarily responsible for bronchoconstriction in this phase?
A) Interleukin-5
B) Histamine
C) Tumor necrosis factor-alpha
D) Leukotrienes
Answer: B) Histamine
Rationale: The early-phase response (occurring within minutes of
allergen exposure) is primarily mediated by histamine released from
mast cells. Histamine causes bronchoconstriction, mucus secretion, and
vasodilation. Interleukin-5 (A) promotes eosinophil activation. TNF-
alpha (C) is involved in chronic inflammation. Leukotrienes (D)
contribute to both early and late-phase responses.
3. Which of the following statements accurately describes the late-
phase asthmatic response?
, 4|Page
A) Occurs within minutes of allergen exposure and resolves quickly
B) Occurs 4-8 hours after exposure and involves inflammatory cell
infiltration
C) Is not responsive to bronchodilator therapy
D) Only occurs in patients with severe asthma
Answer: B) Occurs 4-8 hours after exposure and involves
inflammatory cell infiltration
Rationale: The late-phase response occurs 4-8 hours after allergen
exposure and involves recruitment of inflammatory cells (eosinophils,
neutrophils, T lymphocytes) to the airways. This response contributes to
airway hyperresponsiveness and chronic inflammation. Option A
describes the early-phase response. The late-phase response is partially
responsive to bronchodilators (C) and can occur in mild to severe asthma
(D).
4. A nurse is teaching a patient about airway remodeling in asthma.
Which of the following is a consequence of chronic, uncontrolled
airway inflammation?
A) Reversible bronchoconstriction
B) Permanent structural changes including subepithelial fibrosis and
smooth muscle hypertrophy
C) Decreased mucus production
D) Resolution of airway hyperresponsiveness
Answer: B) Permanent structural changes including subepithelial
fibrosis and smooth muscle hypertrophy
Rationale: Airway remodeling is a consequence of chronic, untreated
inflammation. It involves subepithelial fibrosis (collagen deposition),
smooth muscle hypertrophy and hyperplasia, goblet cell hyperplasia, and
